Doctor profile · Federal record
Dr. LIAT DAGAN, MD
Medical Oncology Physician (CMS: HEMATOLOGY) · Hematology & Oncology Physician · Hematology & Oncology Physician · BOCA RATON, FL
- NPI 1518167451
- Accepts Medicare
- MIPS 69.1 / 100 · 2023
- 31 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
701 NW 13TH ST FL 2
BOCA RATON, FL 334862305
(561) 955-6400
fax (561) 955-6618 - Mailing address
-
6282 LINTON BLVD
DELRAY BEACH, FL 334846416
Credentials & registration
- NPI registered
- July 2007 — 19 yrs on file
- Profile last updated
- February 16, 2022
- Year of graduation
- 1995 — 31 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State licenses (2)
- Florida #105551 · Florida #ME105551
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1518167451. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,008
Distinct HCPCS
10
Medicare allowed
$218,186
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 673 | 305 | $102 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 435 | 206 | $102 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 215 | 106 | $124 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 164 | 112 | $69 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 123 | 121 | $181 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 100 | 77 | $69 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 93 | 93 | $140 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 71 | 55 | $83 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 57 | 57 | $140 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 53 | 38 | $149 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 1,804. This provider delivers 1.1× the peer median.Open Payments
Industry payments received
All-time total
$1,600
Transactions
56
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 13 | $264.42 | |
| GENZYME CORPORATION | 6 | $155.90 | |
| SOBI, INC | 3 | $117.91 | |
| Novartis Pharmaceuticals Corporation | 5 | $110.87 | |
| Incyte Corporation | 3 | $106.45 | |
| Merck Sharp & Dohme LLC | 4 | $92.64 | |
| AstraZeneca Pharmaceuticals LP | 4 | $86.08 | |
| Genentech USA, Inc. | 3 | $76.46 | |
| ABBVIE INC. | 3 | $71.40 | |
| GlaxoSmithKline, LLC. | 3 | $66.05 | |
| Adaptive Biotechnologies Corporation | 2 | $64.69 | |
| Rigel Pharmaceuticals, Inc. | 2 | $57.03 | |
| Alexion Pharmaceuticals, Inc. | 2 | $48.86 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $37.29 | |
| TerSera Therapeutics LLC | 1 | $33.25 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
373
Patients
50
Total drug cost
$3,081,451
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 75 | 18 | $69,921 |
| Hydroxyurea | Generic | 68 | 21 | $2,655 |
| Revlimid (Lenalidomide) | Brand | 44 | 0 | $717,304 |
| Xarelto (Rivaroxaban) | Brand | 30 | 11 | $30,846 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 23 | 0 | $412,373 |
| Pomalyst (Pomalidomide) | Brand | 21 | 0 | $503,735 |
| Calquence (Acalabrutinib Maleate) | Brand | 17 | 0 | $271,085 |
| Brukinsa (Zanubrutinib) | Brand | 16 | 0 | $246,142 |
| Imbruvica (Ibrutinib) | Brand | 16 | 0 | $192,534 |
| Lenalidomide | Generic | 15 | 0 | $182,774 |